Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
UCB Pharma (United States)
InstitutionResearch output, impact & collaborations
UCB Pharma (United States) is a research organisation in Atlanta, US. OpenAlex records 927 works and 49,708 citations for it. 181 researchers list it as their most recent affiliation.
927
Works
49,708
Citations
181
Researchers
15
Avg h-index
How has UCB Pharma (United States)'s publication output changed over time?
ScholarIQpublication output · 2016–2025
Output grew0% over the shown period — from 1 works in 2016 to 1 in 2025.
1
1
2
1
1
3
1
2016202020212022202320242025
Who are the most-cited researchers behind UCB Pharma (United States)?
ScholarIQtop researchers by citations
What are the most-cited papers on UCB Pharma (United States)?
ScholarIQmost cited works
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2− Metastatic Breast Cancer in Postmenopausal Women in the USA
Prajakta P. Masurkar, Haluk Damgacioglu, Ashish A. Deshmukh, Meghana V. Trivedi
PharmacoEconomics. 202326 Citations
Risk of Serious Adverse Events Associated With Individual Cholinesterase Inhibitors Use in Older Adults With Dementia: A Population-Based Cohort Study
Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Hua Chen, Michael L. Johnson, Rajender R. Aparasu
S37256505. 202218 Citations
Cost-effectiveness of CDK4/6 inhibitors in HR+/HER2− metastatic breast cancer: a systematic review and meta-analysis
Prajakta P. Masurkar, Prachi Prajapati, Joanne Canedo, Swarnali Goswami, Sally Earl, Kaustuv Bhattacharya
Current Medical Research and Opinion. 202411 Citations
Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia
Prajakta P. Masurkar, Satabdi Chatterjee, Jeffrey T. Sherer, Rajender R. Aparasu
S37256505. 20218 Citations
A naturalistic observation study of medication counseling practices at retail chain pharmacies
S. Yande, Prajakta P. Masurkar, Suma Gopinathan, Sujit S. Sansgiry
Pharmacy Practice. 20207 CitationsOPEN ACCESS
How much of the research on UCB Pharma (United States) is open access?
ScholarIQopen access share
40%OPEN ACCESS
Gold
20%
Green
10%
Hybrid
10%
Bronze
0%
Closed
60%